Semaglutide
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
Novo Nordisk · Phase 3 · Completed · Enrollment 407
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| semaglutide 2.4 mg | n/r | n/r | n/r | n/r | n/r |
| semaglutide 2.4 mg (placebo) | 59 participants | 21 participants | 21 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.